Cooling with molecules
Researchers at the universities in Bielefeld, Manchester, and Zaragoza present low-temperature experiment in Nature Communications
2014-10-22
(Press-News.org) This news release is available in German.
An international team of scientists have become the first ever researchers to successfully reach temperatures below minus 272.15 degrees Celsius – only just above absolute zero – using magnetic molecules. The physicists and chemists are presenting their new investigation today (22 October 2014) in the scientific journal Nature Communications. It was developed by six scientists from Bielefeld University, the University of Manchester (Great Britain), and the Universidad de Zaragoza (Spain).
Scientists usually express temperatures on the Kelvin scale. Minus 272.15 degrees Celsius is precisely one Kelvin. This is why the researchers call their development 'sub-Kelvin cooling'. Cold temperatures are generally obtained by using an effect that anyone can observe with an aerosol can. If you press the button on the can for long enough, you will notice that whatever is being sprayed out gets colder. A normal refrigerator also uses this effect. In both cases, a gaseous refrigerant cools down as it expands due to the drop from high to low pressure.
But how can we reach really low temperatures in the low Kelvin range? Nowadays, this is done by using helium as the refrigerant. However, helium is becoming increasingly scarce. 'The very rare helium-3 isotope with which one can also get down to a few tenths of a Kelvin is now practically unaffordable,' says Professor Dr. Jürgen Schnack, co-author of the study and physicist at Bielefeld University. Magnetic substances can also be used as refrigerants. These particularly include paramagnetic salts. Their cooling has nothing to do with pressure. They cool down when the external magnetic field generated by, for example, an electromagnet decreases. When the electric current is reduced in the coil, the magnetic field also decreases and the paramagnetic salts cool down.
In their article, the scientists from Zaragoza, Manchester, and Bielefeld report on successful sub-Kelvin cooling with an alternative medium – magnetic molecules. These are molecules containing magnetic ions such as gadolinium. 'Nowadays, these can be produced in large quantities so that they are readily available compared to helium,' says Professor Eric J. L. McInnes PhD, the head of the research team at the University of Manchester where the molecules studied were synthesized.
The magnetic molecule with which he and his colleagues have been experimenting is called 'Gd7' in short. Very appropriately, it has the geometric structure of a snowflake. As the computer simulations by Professor Schnack's research team show, it starts of by cooling down in a decreasing magnetic field; then it warms up again before finally cooling down once more as the magnetic field disappears. 'We were really excited when the theoretical computations were able to explain this complex behaviour in detail,' says the Professor of Theoretical Physics. 'Compared to paramagnetic salts in which the temperature drops continuously as the magnetic field declines, molecules such as Gd7 behave in more complex ways. They can be used to get down to really low temperatures without switching off the magnetic field completely,' reports Dr. Marco Evangelisti whose team at the Universidad de Zaragoza carried out the low-temperature experiments.
'You have to know that such simulations work with gigantic matrices, that is, special number fields. We are happy to have a powerful supercomputer in Bielefeld for this purpose,' says Schnack. The researcher reports that the computer system is not just invaluable for the project on magnetic cooling but also for the DFG Research Unit 945 'Nanomagnets', funded by the German Research Foundation (DFG).
Jürgen Schnack has been studying magnetic molecules for 15 years. These often, but not always, have an organic backbone composed of carbon, hydrogen, and oxygen in which special metal ions such as iron ions are bound together. Each of these iron particles functions as a tiny magnetic needle with neighbouring particles working together like a larger magnet. The goal of research on magnetic molecules is to design them so that they exactly fit various applications: as transparent magnets, as nano data memoires, or even as cooling molecules.
INFORMATION:
Original publication:
Joseph W. Sharples, David Collison, Eric J. L. McInnes, Jürgen Schnack, Elias Palacios, Marco Evangelisti: Quantum signatures of a molecular nanomagnet in direct magnetocaloric measurements. Nature Communications, http://www.nature.com/ncomms/2014/141022/ncomms6321/full/ncomms6321.html, http://dx.doi.org/10.1038/ncomm6321, published on 22 October 2014.
Further information is available online at:
http://obelix.physik.uni-bielefeld.de/~schnack/index-research.html
ELSE PRESS RELEASES FROM THIS DATE:
2014-10-22
Though most NCAA colleges and universities have created programs to help athletes deal with concussions, a new Harvard study has found that, when it comes to specific components of those plans, many institutions still lag behind accepted standards.
The study, the first-ever comprehensive examination of how colleges and universities have complied with the Concussion Policy and Legislation adopted by the NCAA in 2010, is based on the results of a survey sent to all 1,066 NCAA member institutions. Of those institutions, 907 schools responded.
The results, according to ...
2014-10-22
BOSTON – It is an intricate network of activity that enables breast cancer cells to move from the primary breast tumor and set up new growths in other parts of the body, a process known as metastasis.
Now a research team led by investigators at Beth Israel Deaconess Medical Center (BIDMC) has identified an unexpected link between a transcription factor known to regulate speech and language development and metastatic colonization of breast cancer.
Currently described online in Cell Stem Cell, the new findings demonstrate that, when silenced, the FOXP2 transcription ...
2014-10-22
October 22, 2014 – In contrast to national trends, a study performed at Alabama's largest hospital finds no racial difference in the risk of pregnancy-related death between African American and Caucasian women, reports the November issue of Anesthesia & Analgesia.
However, the results show a significant increase in maternal mortality for women who live greater distances from the hospital, according to the study Dr Michael Froelich of University of Alabama at Birmingham (UAB) and colleagues. The findings point to differences in health care access as a possible explanation ...
2014-10-22
A large international clinical trial has shed new light on the effectiveness of current hospital protocols for managing blood pressure in stroke patients.
The two-part ENOS trial (Efficacy of Nitric Oxide in Stroke,) was carried out at The University of Nottingham in collaboration with 23 countries to try to solve two major conundrums faced by doctors when treating people who have suffered a stroke — should blood pressure be lowered using medicated skin patches, and should existing blood pressure medication be stopped or continued after a stroke?
The results of ...
2014-10-22
PITTSBURGH, Oct. 22, 2014 – Children with autism spectrum disorder (ASD) were more likely to have been exposed to higher levels of certain air toxics during their mothers' pregnancies and the first two years of life compared to children without the condition, according to the preliminary findings of a University of Pittsburgh Graduate School of Public Health investigation of children in southwestern Pennsylvania.
This research, funded by The Heinz Endowments, will be presented today at the American Association for Aerosol Research annual meeting in Orlando, Fla. ...
2014-10-22
A painful inflamed lesion on the oral mucosa, which often seems to be burning at the periphery: every third individual has at one point had such a lesion—an aphthous ulcer. Often they resolve after a brief period of time. In 2% to 10% of patients these lesions are recurrent and require medical treatment. Unfortunately, as Andreas Altenberg and co-authors point out in a current review on the therapy of aphthous ulcers (Dtsch Arztebl Int 2014; 111: 665–73), the etiology of these lesions is unclear. Thus aphthous ulcers can only be treated symptomatically.
Even ...
2014-10-22
Boston, MA – A research team led by Brigham and Women's Hospital (BWH) has developed and tested a novel nanoparticle platform that efficiently delivers clinically important proteins in vivo in initial proof-of-concept tests. Nanoparticles, which are particles measuring nanometers in size, hold promise for a range of applications, including human therapeutics. The key advantage of the new platform, known as a thermosponge nanoparticle, is that it eliminates the need for harsh solvents, which can damage the very molecules the particles are designed to carry.
The study ...
2014-10-22
(Sacramento, CA): Broad-spectrum prevention that can simultaneously prevent unintended pregnancy along with STIs, including HIV, is on the horizon say experts in a special supplement of the BJOG: An International Journal of Obstetrics and Gynaecology. The issue features an international assemblage of researchers, funders, developers and advocates who identify the pressing global health rationale for MPTs and present new research and strategies for making the go/no-go funding and research decisions that shape the field.
The invited guest editor for the supplement is Dr. ...
2014-10-22
A review of sentencing following the 2011 English riots has shown that sentences were much harsher than realised at first.
And just as people got caught up in the riots and acted out of character the study, carried out by The University of Manchester and Liverpool John Moores University, found that the courts themselves got caught up in a similar kind of collective hysteria.
Dr Hannah Quirk, a Senior Lecturer in Criminal Law and Justice from The University of Manchester, was the co-author of the research which has just been published in The British Journal of Criminology. ...
2014-10-22
Our immune system defends us from harmful bacteria and viruses, but, if left unchecked, the cells that destroy those invaders can turn on the body itself, causing auto-immune diseases like type-1 diabetes or multiple sclerosis. A molecule called insulin-like growth factor-1 (IGF-1) boosts the body's natural defence against this 'friendly fire', scientists at the European Molecular Biology Laboratory (EMBL) in Monterotondo, Italy, have found. The findings, published today in EMBO Molecular Medicine, are especially exciting because IGF-1 is already approved for use in patients, ...
LAST 30 PRESS RELEASES:
[Press-News.org] Cooling with molecules
Researchers at the universities in Bielefeld, Manchester, and Zaragoza present low-temperature experiment in Nature Communications